162 related articles for article (PubMed ID: 11161859)
1. The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma.
Toy EP; Chambers JT; Kacinski BM; Flick MB; Chambers SK
Gynecol Oncol; 2001 Feb; 80(2):194-200. PubMed ID: 11161859
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
3. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
4. Colony-stimulating factor-1 and its receptor do not have a role in the pathogenesis of uterine sarcomas.
Anderson PS; Smith HO; Goldberg GL; Fields AL; Runowicz CD; Pollard JW
Gynecol Oncol; 1999 Aug; 74(2):202-7. PubMed ID: 10419732
[TBL] [Abstract][Full Text] [Related]
5. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
6. Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.
Flick MB; Sapi E; Perrotta PL; Maher MG; Halaban R; Carter D; Kacinski BM
Oncogene; 1997 May; 14(21):2553-61. PubMed ID: 9191055
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
8. Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomas.
Bauknecht T; Kiechle-Schwarz M; du Bois A; Wölfle J; Kacinski B
Cancer Detect Prev; 1994; 18(3):231-9. PubMed ID: 8076385
[TBL] [Abstract][Full Text] [Related]
9. Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.
Richardsen E; Sørbye SW; Crowe JP; Yang JL; Busund LT
Anticancer Res; 2009 Oct; 29(10):3861-6. PubMed ID: 19846920
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.
Maher MG; Sapi E; Turner B; Gumbs A; Perrotta PL; Carter D; Kacinski BM; Haffty BG
Clin Cancer Res; 1998 Aug; 4(8):1851-6. PubMed ID: 9717811
[TBL] [Abstract][Full Text] [Related]
11. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
13. Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.
Sapi E; Flick MB; Rodov S; Gilmore-Hebert M; Kelley M; Rockwell S; Kacinski BM
Cancer Res; 1996 Dec; 56(24):5704-12. PubMed ID: 8971179
[TBL] [Abstract][Full Text] [Related]
14. PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma.
Davidson B; Goldberg I; Gotlieb WH; Kopolovic J; Ben-Baruch G; Reich R
Clin Cancer Res; 2003 Apr; 9(4):1412-9. PubMed ID: 12684413
[TBL] [Abstract][Full Text] [Related]
15. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
17. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
18. cAMP inhibits CSF-1-stimulated tyrosine phosphorylation but augments CSF-1R-mediated macrophage differentiation and ERK activation.
Wilson NJ; Cross M; Nguyen T; Hamilton JA
FEBS J; 2005 Aug; 272(16):4141-52. PubMed ID: 16098196
[TBL] [Abstract][Full Text] [Related]
19. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.
Cross M; Csar XF; Wilson NJ; Manes G; Addona TA; Marks DC; Whitty GA; Ashman K; Hamilton JA
Biochem J; 2004 May; 380(Pt 1):243-53. PubMed ID: 14969583
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.
Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR
Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]